Sana Biotechnology Inc Sustainability Reports
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines. The company creates and develops ex vivo and in vivo cell engineering platforms to treat diseases including oncology, diabetes, central nervous system disorders, and autoimmune conditions.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00N5BMH70
4 reports from 2020 to 2023